Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2012-05-17

FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for alendronate sodium by Aurobindo Pharma Limited, indicating a modification to an already approved product's label or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALENDRONATE SODIUM (ALENDRONATE SODIUM)

Snippet

SUPPL AP for ALENDRONATE SODIUM (ALENDRONATE SODIUM)